These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29987222)

  • 1. Interleukin-33: Its Emerging Role in Allergic Diseases.
    Ding W; Zou GL; Zhang W; Lai XN; Chen HW; Xiong LX
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29987222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
    Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
    Front Immunol; 2018; 9():2004. PubMed ID: 30233590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
    Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
    Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
    Cayrol C; Girard JP
    Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways.
    Akasaki S; Matsushita K; Kato Y; Fukuoka A; Iwasaki N; Nakahira M; Fujieda S; Yasuda K; Yoshimoto T
    Int Immunol; 2016 Feb; 28(2):65-76. PubMed ID: 26428949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
    Cayrol C; Girard JP
    Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the role of interleukin-17 and the interleukin-20 family in inflammatory allergic skin diseases.
    Hofmann MA; Kiecker F; Zuberbier T
    Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):451-7. PubMed ID: 27490126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupilumab: Basic aspects and applications to allergic diseases.
    Matsunaga K; Katoh N; Fujieda S; Izuhara K; Oishi K
    Allergol Int; 2020 Apr; 69(2):187-196. PubMed ID: 32007360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate and adaptive type 2 immunity in lung allergic inflammation.
    Kubo M
    Immunol Rev; 2017 Jul; 278(1):162-172. PubMed ID: 28658559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and novel developments in mechanisms of allergic inflammation.
    Han X; Krempski JW; Nadeau K
    Allergy; 2020 Dec; 75(12):3100-3111. PubMed ID: 33068299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal human pathogenic T
    Calise J; Garabatos N; Bajzik V; Farrington M; Robinson D; Jeong D; Londei M; Wambre E
    J Allergy Clin Immunol; 2021 Sep; 148(3):867-875.e4. PubMed ID: 33662368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-33, friend and foe in type-2 immune responses.
    Hardman C; Ogg G
    Curr Opin Immunol; 2016 Oct; 42():16-24. PubMed ID: 27254379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pollen/TLR4 Innate Immunity Signaling Initiates IL-33/ST2/Th2 Pathways in Allergic Inflammation.
    Li J; Zhang L; Chen X; Chen D; Hua X; Bian F; Deng R; Lu F; Li Z; Pflugfelder SC; Li DQ
    Sci Rep; 2016 Oct; 6():36150. PubMed ID: 27796360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of IL-33 and IL-17 in allergic disorders.
    Gupta RK; Gupta K; Dwivedi PD
    Cytokine Growth Factor Rev; 2017 Dec; 38():22-36. PubMed ID: 29153708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases.
    Vocca L; Di Sano C; Uasuf CG; Sala A; Riccobono L; Gangemi S; Albano GD; Bonanno A; Gagliardo R; Profita M
    Immunobiology; 2015 Aug; 220(8):954-63. PubMed ID: 25747940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of thymic stromal lymphopoietin, IL-33, and their receptors in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps.
    Liao B; Cao PP; Zeng M; Zhen Z; Wang H; Zhang YN; Hu CY; Ma J; Li ZY; Song J; Liu JX; Peng LY; Liu Y; Ning Q; Liu Z
    Allergy; 2015 Sep; 70(9):1169-80. PubMed ID: 26095319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-487b mitigates allergic rhinitis through inhibition of the IL-33/ST2 signaling pathway.
    Liu HC; Liao Y; Liu CQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8076-8083. PubMed ID: 30556842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated delivery of soluble ST2 attenuates ovalbumin-induced allergic asthma in mice.
    Yin H; Li XY; Liu T; Yuan BH; Zhang BB; Hu SL; Gu HB; Jin XB; Zhu JY
    Clin Exp Immunol; 2012 Oct; 170(1):1-9. PubMed ID: 22943195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-33 and IL-33 receptors in host defense and diseases.
    Oboki K; Ohno T; Kajiwara N; Saito H; Nakae S
    Allergol Int; 2010 Jun; 59(2):143-60. PubMed ID: 20414050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulated SHARPIN may accelerate the development of atopic dermatitis through activating interleukin-33/ST2 signalling.
    Tang L; Wang J; Zhu J; Liang Y
    Exp Dermatol; 2018 Dec; 27(12):1328-1335. PubMed ID: 30230040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.